Suven Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Suven Life Sciences Ltd · Outcome · 05 Nov 2026, 6:59 pm
Suven Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 120 (+30.4% YoY | -66.4% QoQ) ■ EBITDA: -11,092 (-39.0% YoY | +16.3% QoQ) ■ EBITDA Margin (%): -9,254 (-57553 bps YoY | -553791 bps QoQ) ■ PAT: -10,694 (-38.3% YoY | +16.2% QoQ) ■ EPS (INR): -3.77 (-8.3% YoY | +22.1% QoQ)
Original exchange filing (PDF)
More announcements from Suven Life Sciences Ltd
- Please find enclosed the Revised News Release of our company · 16 Nov 2026
- Please find enclosed the News Release of our Company · 16 Nov 2026
- Please find enclosed News Release of our Company · 12 Nov 2026
- Monitoring Agency Report for the quarter ended 30th September, 2026 · 06 Nov 2026
- Un-audited financial results for the quarter and half year ended 30th September 2026 · 05 Nov 2026
- Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026 · 05 Nov 2026
- SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 05 Nov 2026
- SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 05 Nov 2026
